sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
uaagaaacugggagcaaagauau | 3289 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcacauuggaacugagcacuug | 1515 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcacauuggaacugagcacuug | 1515 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcacauuggaacugagcacuug | 1772 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcacauuggaacugagcacuug | 1772 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 806 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 806 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 356 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 356 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 3065 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 3065 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 2000 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 2000 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 2123 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 2123 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 3188 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 3188 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 536 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 536 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 86 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
caguauauuucaggaagguua | 86 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 202 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 202 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 1101 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 1101 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 2565 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 2565 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 652 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 652 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 2775 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ggaaggguaucaagacuacgaac | 2775 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugauaaauauuaagggaagaaac | 2378 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugauaaauauuaagggaagaaac | 2378 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugauaaauauuaagggaagaaac | 3443 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugauaaauauuaagggaagaaac | 3443 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1464 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1464 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1757 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1757 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1721 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1721 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1500 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uuuggccuuugaaaguccuuuca | 1500 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 3031 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 3031 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 2105 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 2105 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 3170 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 3170 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 1966 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugcuagcaguuuauauguaua | 1966 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaaaauggaacauuaacccuac | 697 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaaaauggaacauuaacccuac | 697 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaaaauggaacauuaacccuac | 1130 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaaaauggaacauuaacccuac | 1130 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaaaauggaacauuaacccuac | 247 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaaaauggaacauuaacccuac | 247 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaguucagagugcacuuuggc | 2745 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aacaguucagagugcacuuuggc | 2745 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 1223 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 1223 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 791 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 791 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 71 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 71 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 521 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 521 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 341 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 341 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 949 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agucacuaguagaaaguauaa | 949 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuguacaagugcucaguuccaau | 3608 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuguacaagugcucaguuccaau | 3608 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuguacaagugcucaguuccaau | 3603 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuguacaagugcucaguuccaau | 3603 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuguacaagugcucaguuccaau | 2785 | WO2022072447A1 | SNCA IRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
cuguacaagugcucaguuccaau | 2785 | WO2022072447A1 | COMPOSITIONS À BASE D'ARNI DE SNCA ET LEURS PROCÉDÉS D'UTILISATION POUR TRAITER OU PRÉVENIR DES MALADIES NEURODÉGÉNÉRATIVES ASSOCIÉES À SNCA | 20,220,407 | 224 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uguucacccucagcgaguacugu | 913 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uguucacccucagcgaguacugu | 913 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uguucacccucagcgaguacugu | 743 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uguucacccucagcgaguacugu | 743 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gacagaacuuaguuucuaccucc | 425 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gacagaacuuaguuucuaccucc | 425 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acuuaaagcaaucucugucuugg | 187 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acuuaaagcaaucucugucuugg | 187 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acuuaaagcaaucucugucuugg | 373 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acuuaaagcaaucucugucuugg | 373 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acguaaccuacggugucccgcuaggaaagagaggugcgucaaacagcgacaaguuccgcccacguaaaagaugacgcuuggugugucagccgucccugcugcccgguugcuucucuuuugggggcggggucuagcaagagcagguguggguuuaggagguguguguuuuuguuuuucccacccucucuccccacuacuugcucucacaguacucgcugagggugaacaagaaaagaccugauaaagauuaaccagaagaaaacaaggagggaaacaaccgcagccuguagcaagcucuggaacucaggagucgcgcgcua... | 111 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acguaaccuacggugucccgcuaggaaagagaggugcgucaaacagcgacaaguuccgcccacguaaaagaugacgcuuggugugucagccgucccugcugcccgguugcuucucuuuugggggcggggucuagcaagagcagguguggguuuaggagguguguguuuuuguuuuucccacccucucuccccacuacuugcucucacaguacucgcugagggugaacaagaaaagaccugauaaagauuaaccagaagaaaacaaggagggaaacaaccgcagccuguagcaagcucuggaacucaggagucgcgcgcua... | 111 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucuacuuguccuucacagaaa | 270 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucuacuuguccuucacagaaa | 270 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucuacuuguccuucacagaaa | 501 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucuacuuguccuucacagaaa | 501 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaagaaaagaccugauaaau | 800 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaagaaaagaccugauaaau | 800 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaagaaaagaccugauaaau | 630 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaagaaaagaccugauaaau | 630 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaaccgcagccuguagcaagcu | 1036 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaaccgcagccuguagcaagcu | 1036 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acugugagagcaaguagugggga | 745 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.